Navigation Links


Accuri in Medical News

Researcher Receives Free C6 Flow Cytometer(R) System as First Winner of Accuri Flow Cytometer(R) Creativity Awards Program

-Accuri Is Awarding a Free Bench-Top Flow Cytometer System Twice Yearly to Support Innovative Research and Expand the Use of Flow Cytometry- -Learn More about the Revolutionary Accuri C6 Flow Cytometer at the American Society for Cell Biology Annual Meeting- ANN ARBOR, Mich., Dec...

Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System

- Bench-Top Flow Cytometer Delivers Performance and Features Similar to Market-Leading Systems in an Easy-to-Use, Accessible and Affordable Format - - See the C6 Flow Cytometer in San Diego at the Accuri Booth at Experimental Biology 2008 and at...

Researcher Receives Free Flow Cytometer System as First Winner of Accuri(R) Flow Cytometer Creativity Awards Program

...etry- -Learn More about the Revolutionary accuri C6 Flow Cytometer at the American Society for Cell... ANN ARBOR, Mich., Dec. 11 /PRNewswire/ -- accuri Cytometers Inc., a life sciences company developin...stems, today announced the first recipient of its accuri Flow Cytometer Creativity Awards program . Heathe...
Accuri in Biological Technology

Accuri Cytometers Completes $4 Million Series D Financing

... ANN ARBOR, Mich., July 13 /PRNewswire/ -- accuri Cytometers, Inc. today announced the completion of...estMichigan! Program co-managed by Credit Suisse. accuri will use the proceeds from the Series D financing ...ital to support the rapid market acceptance of the accuri C6 Flow Cytometer(R) System, a revolutionary produ...

Accuri Cytometers Adds Automation to Its Revolutionary C6 Flow Cytometer(R) System With Commercial Launch of CSampler(TM)

...uarters and Operations- -See CSampler at the accuri Booth at Immunology 2009 and at the American Socie...ting- ANN ARBOR, Mich., May 6 /PRNewswire/ -- accuri Cytometers, Inc. today announced the commercial la...mple, reliable and user-friendly automation to the accuri C6 Flow Cytometer(R) System, a revolutionary produ...

MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile

...s that can potentially revolutionize airway management. Ann Arbor-based accuri Cytometers was the winner of the Good to Great Award, given to the Michigan...duced a leap forward in results. The award was accepted by Jennifer Baird, accuri president and CEO. Accuri Cytometers is marketing revolutionary high perfor...

MichBio Expo Will Feature Sessions for Michigan Manufacturers Interested in Entering Medical Device Market

...n to general Q&A, time will be provided for one-on-one discussions with the companies in attendance. Participating MI medical device companies include accuri Cytometers, Atek Medical Manufacturing, Bioflowtech, ISSYS, Keystone Product Development, MedBio, Stryker, Terumo Cardiovascular Systems, ThreeFold Se...

Accuri Cytometers Completes $13 Million Series C Financing

...rcialization of the Revolutionary accuri C6 Flow Cytometer(R) System-- ANN ARBOR, Mich., July 8 /PRNewswire/ -- accuri Cytometers Inc., a life sciences company developin...retum Ventures also participated in the financing. accuri will use the proceeds from the Series C financing ...

Panelists Announced for 2007 Manufacturers Forum

...amberlain, West Michigan Science & Technology Initiative Rob Hess, Michigan Manufacturing Technology Center Michael Kitchen, Atek Rebecca Lehrmann, accuri Cytometers Robert Nesky, MicroMachine Christophe Sevrain, CJPS Enterprises Jim Smyth, Creative Technology Services TBD, Beaumont Hospitals "This ...
Accuri in Biological Products

C6 Flow Cytometer System from Accuri Cytometers, Inc.

Description: Accuri's C6 Flow Cytometer System is a full featured, two laser, six detector analytical flow cytometer system including: the C6 Flow Cytometer, CFlow Software, and a PC for operation and analysis. The C6 Flow Cytometer System provides all the capabilities of the best selling flow cytometers at a f...
Company:Accuri Cytometers, Inc.
Other TagsPrionPrionPollenTripleTripleTripleLinksLinksInfectedInfectedPreventionPreventionPreventionPrecisionPrecisionPrecision
(Date:12/2/2009)...in 90 minutes of hospital arrival, study finds , ... nationwide program to get faster treatment for pe... dramatically reduced the time between hospital ar...hree-quarters of people with STEMI heart attacks -...rn that shows major blockage of a heart artery -- ...
(Date:12/2/2009)...tabolic syndrome, study finds , , WEDNES...,t enough to keep overweight college football play...ion that can lead to heart disease, a new study su...on I colleges and found that two-thirds were obese...roup of conditions that raise the risk for heart d...
(Date:12/2/2009)... Huntington Memorial Hos...of Approval from the Joint Commission, designating... Huntington will join the network of "approved str...y. ,, "This is a significant milestone for th...t for Pasadena and its surrounding communities," s...
(Date:12/2/2009).... 2 Researchers from ar...d cancer research at the annual American Society o...ber 4-8, 2009. ,, Throughout the ASH conferenc...ts, including Chief Medical Officer Barton Kamen, ...ices Hildy Dillon, and Vice President, Research Co...
(Date:12/2/2009)...ec. 2 Care Support of America,s ... Advanced Illness Coordinated Care (AICC) , has be...ars of life as well as improve the quality of life...ncreasing mortality. These are the principal findi...of Managed Care (November 2009). ,, Based ...
Breaking Medicine News(10 mins):Health News:Heart Attack Treatment Speeds Up Nationwide 2Health News:Heart Attack Treatment Speeds Up Nationwide 3Health News:Oversized College Football Players May Face Heart Risks 2Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4
(Date:12/1/2009)...he scientists, one from the United States, the oth..., the leader of his wolf pack, on remote Ellesmere... goal to finally find out what these "North Pole ... of the harshest areas of the world., "We first ...David Mech, a renowned U.S. Geological Survey (USG...
(Date:12/1/2009)...d first, a Monash University-led international res...t the output of the next generation of solar cells...ation with colleagues from the universities of Wol...ye-sensitised solar cells with a three-fold increa...reviously reported tandem dye-sensitised solar cel...
(Date:12/1/2009)...s aren,t just for listening to the radio anymore. ... devices. Research from North Carolina State Unive...gn creating shape-shifting antennas that open the... public safety to military deployment. , Modern ... there are limitations to how far they can be bent...
Breaking Biology News(10 mins):North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Innovation puts next-generation solar cells on the horizon 2Shape shifters: Researchers create new breed of antennas 2Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 12388 1Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 12388 2Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 12388 3Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 12388 4Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 12388 5Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting 12388 6Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 1Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 2Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 3Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 1Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 2Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 3Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 4Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 5
Other Contentsstiffnessstiffnessstiffnessstiffnessstiffnessinductioninductioninductioninductioninductioninductioninductioninductioninductioninductionbirthbirthbirthbirthbirthbirthbirthbirthswitchedswitchedswitchedswitchedswitchedswitchedbabiesbabiesbabiesbabiesbabiesbabiesregulatorregulatorregulatorregulatorregulatorregulatorregulatorregulatorautoimmuneautoimmuneautoimmuneautoimmuneautoimmuneautoimmuneautoimmuneautoimmune